‹ All episodes

The LACNETS Podcast - Top 10 FAQs with neuroendocrine tumor (NET) experts

Episode 25: What to Know about Grade 3 Poorly Differentiated Neuroendocrine Carcinoma (NEC)

September 15, 2023 Learn Advocate Connect Neuroendocrine Tumor Society Season 1 Episode 25
Episode 25: What to Know about Grade 3 Poorly Differentiated Neuroendocrine Carcinoma (NEC)
The LACNETS Podcast - Top 10 FAQs with neuroendocrine tumor (NET) experts
More Info
The LACNETS Podcast - Top 10 FAQs with neuroendocrine tumor (NET) experts
Episode 25: What to Know about Grade 3 Poorly Differentiated Neuroendocrine Carcinoma (NEC)
Sep 15, 2023 Season 1 Episode 25
Learn Advocate Connect Neuroendocrine Tumor Society

What are Grade 3 Poorly Differentiated Neuroendocrine Carcinoma (NEC)? What makes NEC unique? Can a NET transform to NEC? Dr Nitja Raj from Memorial Sloan Kettering Cancer Center in New York City explains NEC tumor biology and how it guides treatment strategy. She also discusses current clinical trials and research.

For more information, visit LACNETS.org/podcast/24. 

For more information, visit LACNETS.org.

Apple Podcasts Spotify Amazon Music Podcast Index Overcast Podcast Addict +
Show Notes

What are Grade 3 Poorly Differentiated Neuroendocrine Carcinoma (NEC)? What makes NEC unique? Can a NET transform to NEC? Dr Nitja Raj from Memorial Sloan Kettering Cancer Center in New York City explains NEC tumor biology and how it guides treatment strategy. She also discusses current clinical trials and research.

For more information, visit LACNETS.org/podcast/24. 

For more information, visit LACNETS.org.